Cliff Babbitt serves as the Director of Solution Architecture at Interlace Health, formerly known as FormFast, where he leverages his extensive background in healthcare information technology to drive innovation and efficiency in patient intake processes. With a strong focus on informed consent and data capture,...
Cliff Babbitt serves as the Director of Solution Architecture at Interlace Health, formerly known as FormFast, where he leverages his extensive background in healthcare information technology to drive innovation and efficiency in patient intake processes. With a strong focus on informed consent and data capture, Cliff collaborates closely with healthcare organizations to identify their unique challenges and develop tailored solutions that enhance operational workflows. His expertise in application design and project management enables him to oversee key projects that streamline signature processes, ultimately improving the patient experience and increasing revenue collection.
At Interlace Health, Cliff plays a pivotal role in the integration of advanced technologies that support seamless patient interactions. His proficiency in solution selling and pre-sales activities allows him to effectively demonstrate the value of Interlace Health’s offerings, ensuring that clients understand how these solutions can transform their operations. By focusing on enhancing integration strategies, Cliff helps organizations reduce costs while building more efficient systems that foster better patient engagement.
In addition to his technical skills, Cliff’s experience in CRM and account management positions him as a trusted advisor to clients, guiding them through the complexities of healthcare IT. His commitment to training and sales support further empowers teams to maximize the benefits of the solutions implemented. As a thought leader in the industry, Cliff Babbitt continues to shape the future of healthcare technology, driving initiatives that not only meet regulatory demands but also elevate the overall patient journey.